Skip to main content
Signal8
Braeden Lichti profile photo

Lichti Braeden

CIK: 0001982476

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

PMGC Holdings Inc. logo
ELAB

PMGC Holdings Inc.

Director
AQUABOUNTY TECHNOLOGIES INC logo
aqb

AQUABOUNTY TECHNOLOGIES INC

Director
Qualigen Therapeutics, Inc. logo
QLGN

Qualigen Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • PMGC Holdings Inc. logo
    ELAB

    PMGC Holdings Inc.

    Jun 1, 2026
    Award(A)

    Options

    Indirect
    450.3K shares-
  • PMGC Holdings Inc. logo
    ELAB

    PMGC Holdings Inc.

    Mar 26, 2025
    Award(A)
    Indirect
    3.3M shares-

1-2 of 2

About Braeden Lichti

Braeden Lichti (SEC CIK 0001982476) files insider reports with the SEC as Director of PMGC Holdings Inc. (ELAB), Director of AQUABOUNTY TECHNOLOGIES INC (AQB) and Director of Qualigen Therapeutics, Inc. (QLGN).

Signal8 holds 4 ownership filings by Braeden Lichti (2 Form 3, 2 Form 4), filed between Oct 17, 2024 and Jun 2, 2026. Those filings report 2 transactions, from Mar 26, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Braeden Lichti's filings is in NEWPORT BEACH, CA.

Recent filings by Braeden Lichti

  • Jun 1, 2026: Grant or award of ELAB derivative securities (Form 4, code A).
  • Mar 26, 2025: Grant or award of ELAB shares (Form 4, code A).

Other insiders filing for PMGC Holdings Inc. (ELAB)

How to read Form 4 transaction codes